These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. Hayashida K; Kanda K; Yaku H; Ando J; Nakayama Y J Thorac Cardiovasc Surg; 2007 Jul; 134(1):152-9. PubMed ID: 17599501 [TBL] [Abstract][Full Text] [Related]
26. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681 [TBL] [Abstract][Full Text] [Related]
27. Cardiac Valve Bioreactor for Physiological Conditioning and Hydrodynamic Performance Assessment. Tefft BJ; Choe JA; Young MD; Hennessy RS; Morse DW; Bouchard JA; Hedberg HJ; Consiglio JF; Dragomir-Daescu D; Simari RD; Lerman A Cardiovasc Eng Technol; 2019 Mar; 10(1):80-94. PubMed ID: 30311149 [TBL] [Abstract][Full Text] [Related]
28. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739 [TBL] [Abstract][Full Text] [Related]
29. The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. Karim N; Golz K; Bader A Artif Organs; 2006 Oct; 30(10):809-14. PubMed ID: 17026581 [TBL] [Abstract][Full Text] [Related]
30. Cyclic Stretch and Perfusion Bioreactor for Conditioning Large Diameter Engineered Tissue Tubes. Schmidt JB; Tranquillo RT Ann Biomed Eng; 2016 May; 44(5):1785-97. PubMed ID: 26307332 [TBL] [Abstract][Full Text] [Related]
31. Functional living trileaflet heart valves grown in vitro. Hoerstrup SP; Sodian R; Daebritz S; Wang J; Bacha EA; Martin DP; Moran AM; Guleserian KJ; Sperling JS; Kaushal S; Vacanti JP; Schoen FJ; Mayer JE Circulation; 2000 Nov; 102(19 Suppl 3):III44-9. PubMed ID: 11082361 [TBL] [Abstract][Full Text] [Related]
32. A bioreactor with compliance monitoring for heart valve grafts. Vismara R; Soncini M; Talò G; Dainese L; Guarino A; Redaelli A; Fiore GB Ann Biomed Eng; 2010 Jan; 38(1):100-8. PubMed ID: 19784774 [TBL] [Abstract][Full Text] [Related]
34. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Mol A; Driessen NJ; Rutten MC; Hoerstrup SP; Bouten CV; Baaijens FP Ann Biomed Eng; 2005 Dec; 33(12):1778-88. PubMed ID: 16389526 [TBL] [Abstract][Full Text] [Related]
35. [Progress in studies of tissue-engineered heart valves]. Wu Z; Shi Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jan; 19(1):132-4. PubMed ID: 11951501 [TBL] [Abstract][Full Text] [Related]
37. A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions. Ramaswamy S; Boronyak SM; Le T; Holmes A; Sotiropoulos F; Sacks MS J Biomech Eng; 2014 Dec; 136(12):121009. PubMed ID: 25321615 [TBL] [Abstract][Full Text] [Related]
38. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464 [TBL] [Abstract][Full Text] [Related]
39. Establishing a protocol to quantify leaflet fibroblast responses to physiologic flow through a viable heart valve. Weston MW; Goldstein S; Epting RE; He S; Mauldin JM; Yoganathan AP ASAIO J; 1997; 43(5):M377-82. PubMed ID: 9360065 [TBL] [Abstract][Full Text] [Related]
40. The relevance of large strains in functional tissue engineering of heart valves. Mol A; Bouten CV; Zünd G; Günter CI; Visjager JF; Turina MI; Baaijens FP; Hoerstrup SP Thorac Cardiovasc Surg; 2003 Apr; 51(2):78-83. PubMed ID: 12730815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]